These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 304182)

  • 1. The renal handling of polybasic drugs. 1. Gentamicin and aprotinin in intact animals.
    Just M; Erdmann G; Habermann E
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):57-66. PubMed ID: 304182
    [No Abstract]   [Full Text] [Related]  

  • 2. The renal handling of polybasic drugs. 2. In vitro studies with brush border and lysosomal preparations.
    Just M; Habermann E
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):67-76. PubMed ID: 304183
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.
    Moestrup SK; Cui S; Vorum H; Bregengård C; Bjørn SE; Norris K; Gliemann J; Christensen EI
    J Clin Invest; 1995 Sep; 96(3):1404-13. PubMed ID: 7544804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal handling of gentamicin and other antibiotics by the isolated perfused rat kidney: mechanism of nephrotoxicity.
    Mitchell CJ; Bullock S; Ross BD
    J Antimicrob Chemother; 1977 Nov; 3(6):593-600. PubMed ID: 599122
    [No Abstract]   [Full Text] [Related]  

  • 5. Potentiation of gentamicin nephrotoxicity in the rat by infusion of aprotinin.
    Morin NJ; Frau A; Nonclercq D; Toubeau G; Zanen J; Heuson-Stiennon JA; Bergeron MG; Beauchamp D; Laurent G
    Exp Mol Pathol; 1994 Jun; 60(3):197-213. PubMed ID: 7525340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal handling of biologically active peptides.
    Just M; Habermann E
    Contrib Nephrol; 1975; 1():62-8. PubMed ID: 1087898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
    Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidermal growth factor precursor in the rat kidney seems to be processed by an aprotinin sensitive proteinase.
    Jørgensen PE; Nexø E; Poulsen SS; Raaberg L
    Agents Actions Suppl; 1992; 38 ( Pt 2)():183-90. PubMed ID: 1281371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
    Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased fractional renal excretion of gentamicin in subtotal nephrectomized dogs.
    Riviere JE; Bowman KF; Rogers RA
    J Pharmacol Exp Ther; 1985 Jul; 234(1):90-3. PubMed ID: 4009507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of gentamicin accumulation in subcellular structures of the mouse kidney.
    Kállay Z; Trnovec T; Kettner M; Macicková T; Navarová J; Gregusková M
    J Pharm Pharmacol; 1982 Apr; 34(4):276-7. PubMed ID: 6124610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Localization of a protease inhibitor in the mouse kidney using immunofluorescence].
    Török P
    Arzneimittelforschung; 1972 Sep; 22(9):1534-8. PubMed ID: 4118857
    [No Abstract]   [Full Text] [Related]  

  • 13. Micropuncture study of the handling of gentamicin by the rat kidney.
    Senekjian HO; Knight TF; Weinman EJ
    Kidney Int; 1981 Mar; 19(3):416-23. PubMed ID: 7241882
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal handling of gentamicin by the Munich-Wistar rat.
    Sheth AU; Senekjian HO; Babino H; Knight TF; Weinman EJ
    Am J Physiol; 1981 Dec; 241(6):F645-8. PubMed ID: 7325235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentamicin pharmacokinetics in rats with reduced renal parenchyma.
    Hatala M; Morávek J; Schück O
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):1-6. PubMed ID: 1150358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of renal low-molecular-weight protein handling in the intact rat.
    Haas M; de Zeeuw D; van Zanten A; Meijer DK
    Kidney Int; 1993 Apr; 43(4):949-54. PubMed ID: 7683068
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of gentamicin among subcellular fractions from rat renal cortex.
    Weinberg JM; Hunt D; Humes HD
    Biochem Pharmacol; 1985 May; 34(10):1779-87. PubMed ID: 4004893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril enhances aminoglycoside nephrotoxicity in potassium-depleted rats.
    Klotman PE; Boatman JE; Volpp BD; Baker JD; Yarger WE
    Kidney Int; 1985 Aug; 28(2):118-27. PubMed ID: 2422431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
    Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
    J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentamicin-specific antiserum alters the disposition of gentamicin by the isolated perfused rat kidney.
    Bekersky I; Popick AC; Colburn WA
    J Lab Clin Med; 1983 Aug; 102(2):205-12. PubMed ID: 6864070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.